Navigation Links
One-Time, One Dose Radiation Treatment Offered For Breast Cancer Patients At MedStar Georgetown University Hospital And MedStar Washington Hospital Center
Date:4/10/2013

WASHINGTON, April 10, 2013 /PRNewswire-USNewswire/ --  For the first time, breast cancer patients in the Washington, DC area have an opportunity to skip the traditional six weeks of radiation after breast cancer surgery and get just one dose in the operating room immediately after having their cancer removed.  Making this possible is INTRABEAM Intraoperative Radiotherapy (IORT) a technology now being offered to patients at both MedStar Georgetown University Hospital and MedStar Washington Hospital Center.

(Photo: http://photos.prnewswire.com/prnh/20130410/DC90549)

Mary Shanholtzer , 68, of Maryland had a one centimeter lump in her breast that was found by a mammogram.  She had a lumpectomy in January 2013 with INTRABEAM IORT given right in the operating room while she was still asleep.  Mary's lymph nodes were negative for cancer, making her a perfect candidate for INTRABEAM IORT. "What attracted me to the IORT is that it's a one shot deal," said Mary. "Six or seven weeks of radiation would have been burdensome for me and working full time, all that travel would have been a problem."

"We're offering INTRABEAM to a select group of lumpectomy patients based on their age, the size and type of tumor," said Shawna Willey, MD, director of the MedStar Regional Breast Health Program. "This is encouraging news for patients who now can wake up from breast surgery and know their radiation treatment is complete instead of facing six weeks of up to 30 radiation treatments."

Up until now, the standard treatment for those having a lumpectomy involved waiting four weeks after the initial surgery and then starting a five to six week whole-breast radiation regimen.

"INTRABEAM changes that," said Marc E. Boisvert, MD, FACS, breast surgeon and medical director of the Center for Breast Health at MedStar Washington Hospital Center. "Now, for a select group of women receiving a lumpectomy, the radiation they receive in the operating room is the only radiation treatment they'll ever need. "

"It's known that most breast cancer recurrences after surgery occur in the same place as the original tumor," said Eleni Tousimis, MD, chief of Breast Surgery at MedStar Georgetown University Hospital. "With INTRABEAM, we are targeting the radiation and only treating the original tumor bed, so we kill any residual cancer cells.  We also spare healthy breast tissue that whole-breast radiation may have negatively affected."

Getting the radiation adds another 20 to 40 minutes to the roughly 90 minute surgery, and the patient is asleep while the treatment is given.

INTRABEAM radiotherapy uses a miniaturized radiation device that generates low energy x-ray radiation. The device is inserted into the tumor bed right after the cancer is removed. The radiation is mostly absorbed over a 1-2 centimeter depth from the tumor cavity.  This allows for a significant reduction in the amount of radiation delivered to the surrounding healthy tissue.

In 2010 the results of a 28-center international study of more than 2200 patients called the TARGIT-A trial concluded that partial breast radiation is just as effective and less toxic when compared to whole-breast radiation for selected patients with early stage breast cancer.  The results were published in the Journal Lancet.

"We know that patient compliance with treatment is part of what determines a good outcome," said Dr. Boisvert. "And we know that the farther away a patient lives from the radiation center the less likely she is to complete her treatment."

"If INTRABEAM IORT had not been an option for me I would have just had more radical surgery, a mastectomy," reflected Mary Shanholtzer . "This technology allowed me to save my life, keep more of my healthy breast and avoid a bigger surgery."

The MedStar Regional Breast Health Program is part of the MedStar Georgetown Cancer Network and combines the experience of internationally-respected experts who provide a wide range of breast care services.  Patients have access to the network's full breadth of clinical diagnoses, personalized treatments, advanced surgical options and clinical trials as well as social workers, nutritionists, nurse navigators and other healthcare professionals.

View press release with video: http://bit.ly/14ZZuX0


'/>"/>
SOURCE MedStar Georgetown University Hospital
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Radiation Oncology Resources, Inc. Is Now The Exclusive US Distributor For Quality Reports [EMR] Software
2. CIVCO Appoints Hap Peterson Vice President of North American Sales for Radiation Oncology
3. Radiation Detection, Monitoring & Safety Market (Geiger Counter, Ionization Chamber, Scintillator, Terahertz detector, Dosimeter, Environment Monitor, Shield, Lead Apron, Eyewear & Glove) - Competitive Analysis & Global Forecasts to 2017
4. Radiation Detection/Protection Market Worth $1,231 Million - 2017
5. Elektas New Radiation Oncology Technology to Shape the Future of Cancer Care
6. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
7. Global Market for Radiation Therapy Equipment to Reach $6.8 Billion by 2018
8. Quebec Clinic Launches Canadian Use of Elektas Agility Beam-Shaping Innovation for Radiation Therapy of Cancer
9. Scatter Radiation from Mammography Presents No Cancer Risk
10. 90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
11. Presentations at Leading Radiation Oncology Meeting Highlight CyberKnife Prostate Outcomes from Patients at More Than 40 Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):